SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma
Anand Velusamy(Guy's and St Thomas' NHS Foundation Trust), Paul Carroll(Guy's and St Thomas' NHS Foundation Trust), Leigh Breen(Leicester General Hospital), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Mufaddal Moonim(Charing Cross Hospital), Audrey Jacques(Guy's and St Thomas' NHS Foundation Trust), Johnathan Hubbard(St Thomas' Hospital), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Rupert Obholzer(Guy's and St Thomas' NHS Foundation Trust), Barbara McGowan(Guy's and St Thomas' NHS Foundation Trust)
Cited by 0
Related Papers
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Skeletal muscle protein metabolism in the elderly: Interventions to counteract the 'anabolic resistance' of ageing
|Nutrition & Metabolism|2011|542
Appetite control
|Journal of Endocrinology|2005|431